Close

SLC6A1

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

The SLC6A1 gene encodes a gammaaminobutyric acid (GABA) transporter, which removes GABA from the synaptic cleft.Terminates the action of GABA by its high affinity sodiumdependent reuptake into presynaptic terminals.
  • CAR Vector Products

Loading...
  • Target Species:
  • Antibody Clone:
  • Antibody Host:
  • Receptor Construction:
  • Vector Type:
  • Targeting Cell Type:
CAT Product Name Target Species Antibody Clone Antibody Host Receptor Construction Vector Type Targeting Cell Type CAR Vector Type Inquiry & Datasheet
CAR-0120ZP1585 Anti-SLC6A1 (DS3307AB) h(CD28-CD3ζ) CAR, pCDCAR1 Rabbit DS3307AB Rabbit scFv-CD28-CD3ζ Lentiviral vector T Cell   Add to Cart   Datasheet
CAR-0120ZP1586 Anti-SLC6A1 (DS3307AB) h(4-1BB-CD3ζ) CAR, pCDCAR1 Rabbit DS3307AB Rabbit scFv-4-1BB-CD3ζ Lentiviral vector T Cell   Add to Cart   Datasheet
CAR-0120ZP1587 Anti-SLC6A1 (BA0122) h(CD28-CD3ζ) CAR, pCDCAR1 Rabbit BA0122 Rabbit scFv-CD28-CD3ζ Lentiviral vector T Cell   Add to Cart   Datasheet
CAR-0120ZP1588 Anti-SLC6A1 (BA0122) h(4-1BB-CD3ζ) CAR, pCDCAR1 Rabbit BA0122 Rabbit scFv-4-1BB-CD3ζ Lentiviral vector T Cell   Add to Cart   Datasheet
CAR-0120ZP1589 Anti-SLC6A1 (BA0121) h(CD28-CD3ζ) CAR, pCDCAR1 Rabbit BA0121 Rabbit scFv-CD28-CD3ζ Lentiviral vector T Cell   Add to Cart   Datasheet
CAR-0120ZP1590 Anti-SLC6A1 (BA0121) h(4-1BB-CD3ζ) CAR, pCDCAR1 Rabbit BA0121 Rabbit scFv-4-1BB-CD3ζ Lentiviral vector T Cell   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.